Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-21-013815
Filing Date
2021-03-29
Accepted
2021-03-29 16:35:42
Documents
1
Period of Report
2021-03-25

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6835
  Complete submission text file 0000899243-21-013815.txt   8316
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Issuer) CIK: 0001133416 (see all company filings)

EIN.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 4908 SOUTH ASHTON COURT SPOKANE WA 99223
Business Address
CZIRR JAMES C (Reporting) CIK: 0001260641 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31791 | Film No.: 21782143